Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lingxiang Jin
MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism
PLoS ONE
Multidisciplinary
Related publications
Active Glycolytic Metabolism in CD133(+) Hepatocellular Cancer Stem Cells: Regulation by MIR-122
Oncotarget
Oncology
Cx32 Reverses Epithelial-Mesenchymal Transition in Doxorubicin-Resistant Hepatocellular Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
miR-122 Regulates Hepatic Lipid Metabolism and Tumor Suppression
Journal of Clinical Investigation
Medicine
Hepatocellular Carcinoma Cells Surviving Doxorubicin Treatment Exhibit Increased Migratory Potential and Resistance to Doxorubicin Re-Treatment In�vitro
Oncology Letters
Cancer Research
Oncology
MiR-139-5p Reverses CD44+/CD133+-associated Multidrug Resistance by Downregulating NOTCH1 in Colorectal Carcinoma Cells
Oncotarget
Oncology
Lamc1 Promotes the Warburg Effect in Hepatocellular Carcinoma Cells by Regulating PKM2 Expression Through AKT Pathway
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis
Clinical Cancer Research
Cancer Research
Oncology
808. Oncolytic Adenoviral Vector Targeted to Hepatocellular Carcinoma Expressing Low Levels of miR-122
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
The Contribution of miR-122 to the Innate Immunity by Regulating Toll-Like Receptor 4 in Hepatoma Cells
BMC Gastroenterology
Medicine
Gastroenterology
